Yuan Zhi
Stock Analyst at B. Riley Securities
(3.03)
# 1,236
Out of 5,172 analysts
34
Total ratings
43.75%
Success rate
2.48%
Average return
Main Sectors:
Stocks Rated by Yuan Zhi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CATX Perspective Therapeutics | Maintains: Buy | $11 → $13 | $4.45 | +192.13% | 5 | Mar 18, 2026 | |
| TOI The Oncology Institute | Maintains: Buy | $6 → $8 | $3.32 | +140.96% | 2 | Mar 13, 2026 | |
| RADX Radiopharm Theranostics | Reiterates: Buy | $13 → $16 | $4.80 | +233.68% | 3 | Dec 16, 2025 | |
| RDNT RadNet | Maintains: Buy | $71 → $87 | $61.49 | +41.49% | 2 | Dec 1, 2025 | |
| TNGX Tango Therapeutics | Maintains: Buy | $8 → $14 | $19.42 | -27.91% | 3 | Nov 18, 2025 | |
| MIR Mirion Technologies | Reiterates: Buy | $17 → $22 | $18.45 | +19.24% | 3 | Jul 23, 2025 | |
| HYPR Hyperfine | Maintains: Buy | $1.2 → $1 | $1.24 | -19.35% | 2 | May 15, 2025 | |
| AGEN Agenus | Maintains: Buy | $42 → $18 | $3.71 | +385.18% | 2 | Aug 14, 2024 | |
| CYRX Cryoport | Upgrades: Buy | $19 → $15 | $8.04 | +86.57% | 4 | Jul 31, 2024 | |
| CTSO Cytosorbents | Reiterates: Buy | $3 | $0.66 | +354.55% | 1 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $61 → $79 | $20.19 | +291.28% | 3 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $16 | $1.11 | +1,341.44% | 4 | Dec 11, 2023 |
Perspective Therapeutics
Mar 18, 2026
Maintains: Buy
Price Target: $11 → $13
Current: $4.45
Upside: +192.13%
The Oncology Institute
Mar 13, 2026
Maintains: Buy
Price Target: $6 → $8
Current: $3.32
Upside: +140.96%
Radiopharm Theranostics
Dec 16, 2025
Reiterates: Buy
Price Target: $13 → $16
Current: $4.80
Upside: +233.68%
RadNet
Dec 1, 2025
Maintains: Buy
Price Target: $71 → $87
Current: $61.49
Upside: +41.49%
Tango Therapeutics
Nov 18, 2025
Maintains: Buy
Price Target: $8 → $14
Current: $19.42
Upside: -27.91%
Mirion Technologies
Jul 23, 2025
Reiterates: Buy
Price Target: $17 → $22
Current: $18.45
Upside: +19.24%
Hyperfine
May 15, 2025
Maintains: Buy
Price Target: $1.2 → $1
Current: $1.24
Upside: -19.35%
Agenus
Aug 14, 2024
Maintains: Buy
Price Target: $42 → $18
Current: $3.71
Upside: +385.18%
Cryoport
Jul 31, 2024
Upgrades: Buy
Price Target: $19 → $15
Current: $8.04
Upside: +86.57%
Cytosorbents
May 15, 2024
Reiterates: Buy
Price Target: $3
Current: $0.66
Upside: +354.55%
Feb 1, 2024
Maintains: Buy
Price Target: $61 → $79
Current: $20.19
Upside: +291.28%
Dec 11, 2023
Maintains: Buy
Price Target: $20 → $16
Current: $1.11
Upside: +1,341.44%